Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03AJF
|
|||
| Drug Name |
SPN-810
|
|||
| Synonyms |
Molindone hydrochloride; 15622-65-8; Molindone HCl; Lidone; Molindone (hydrochloride); EN-1733A; EN 1733 A; EN300-51039; 3-Ethyl-1,5,6,7-tetrahydro-2-methyl-5-(4-morpholinylmethyl)-4H-indol-4-one hydrochloride; Indol-4(5H)-one, 3-ethyl-6,7-dihydro-2-methyl-5-(morpholinomethyl)-, monohydrochloride; DSSTox_RID_80866; DSSTox_CID_25417; DSSTox_GSID_45417; 3-ethyl-2-methyl-5-(morpholin-4-ylmethyl)-4,5,6,7-tetrahydro-1H-indol-4-one hydrochloride; SMR000499578; 3-Ethyl-6,7-dihydro-2-methyl-5-morpholinomethylindo
Click to Show/Hide
|
|||
| Indication | Attention deficit hyperactivity disorder [ICD-11: 6A05.Z; ICD-9: 314] | Phase 3 | [1] | |
| Company |
Supernus Pharmaceuticals Rockville, MD
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H25ClN2O2
|
|||
| Canonical SMILES |
CCC1=C(NC2=C1C(=O)C(CC2)CN3CCOCC3)C.Cl
|
|||
| InChI |
1S/C16H24N2O2.ClH/c1-3-13-11(2)17-14-5-4-12(16(19)15(13)14)10-18-6-8-20-9-7-18;/h12,17H,3-10H2,1-2H3;1H
|
|||
| InChIKey |
GQWNECFJGBQMBO-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 15622-65-8
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:6966
|
|||
| ADReCS Drug ID | BADD_D01488 | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.